Though the liver tissue is one of the top organs with efficient ASO distribution [46], the HB-EGF ASO administration significantly suppressed HB-EGF expression in the aorta, which may contribute to the protection against development of aneurysm and atherosclerosis. The gene discussed is GSTM1; the disease is atherosclerosis.